Vitamin D and ED: A Small Trial Adds a Qualified Result
A small randomized trial reports better erection-function scores when men with low vitamin D received supplementation alongside tadalafil. The result concerns a defined group with a documented deficiency. It does not show that vitamin D treats ED in men whose levels already meet their needs.
The August Trial
Scientific Reports published the study on August 18, 2026. Researchers at two clinics in Iran randomized 40 men with ED and vitamin D levels between 10 and 30 ng/mL to tadalafil plus vitamin D3 or tadalafil plus placebo for 10 weeks. Both groups received the ED medicine.
The vitamin D group finished with a higher erection-function score: 21.7 compared with 18.4. That difference remained statistically significant after adjustment for multiple comparisons. The difference in the total sexual-function questionnaire score did not survive that correction. The study therefore gives a more limited result than a claim that every aspect of sexual function improved.
A Larger Trial Asked a Different Question
The D-Health trial previously examined vitamin D supplementation and ED in older Australian men over several years. Its analysis found no reduction in the prevalence or severity of ED with supplementation. That finding does not automatically contradict a short study of men selected for low vitamin D who also take an ED medicine.
The populations, duration, and treatment questions differ. A supplement might behave differently when it corrects a deficiency than when researchers give it to an unselected population. Equally, a favorable result in 40 patients cannot override a larger trial by itself. Researchers need studies that can identify who benefits, how much benefit to expect, and whether it lasts.
What the Wider Evidence Shows
A systematic review of vitamin D and ED found that observational studies often associate low levels with worse erection function, while intervention studies give inconsistent results. That distinction matters. Two conditions can occur together because they share contributors, and correcting one measurement does not necessarily remove the other condition.
For example, a man can have low vitamin D and an erection problem that also involves diabetes, medicines, anxiety, or circulation. Treating a deficiency may form part of his care without serving as a complete ED treatment. A research headline should not encourage him to stop a prescribed medicine or postpone an assessment of persistent symptoms.
The Trial Dose Is Not a Self-treatment Instruction
The investigators used a high-dose weekly regimen under study supervision. NIH's Office of Dietary Supplements warns that excessive vitamin D can cause high calcium levels and other serious problems. The amount appropriate for treating a deficiency may differ from an ordinary daily intake, and a clinician may need to review other supplements and medical conditions.
More is not automatically better. Tell the clinician about multivitamins, separate vitamin D products, and any combination supplements. Different containers can contain the same ingredient. Ask how a proposed course relates to your test result and whether the plan includes reassessment rather than continuing a treatment dose indefinitely.
Three Details That Make the Result Easy to Overread
First, the trial compared combination treatment with tadalafil alone, not vitamin D alone with placebo. It cannot establish that the supplement would work as a replacement for an ED medicine. Second, a questionnaire's erection domain differs from its overall score. Reporting the corrected result avoids presenting all outcomes as equally convincing.
Third, averages do not describe every participant. The study reports a group difference after a short intervention. A future trial needs enough participants and follow-up to test how reproducible that difference is, which patients account for it, and whether any improvement persists after the initial course.
Why the Multiple-comparison Correction Matters
A questionnaire can produce several scores from the same set of participants. Testing each score separately creates more opportunities to find an apparently favorable result by chance. A correction sets a more demanding standard for those comparisons.
In this trial, the erection-specific result met the corrected standard while the overall score did not. That distinction does not erase the finding. It makes the claim more precise and gives the next trial a clearer question to test. Readers should look for the outcome that survived the analysis rather than combine all reported improvements into one promise.
Using the Finding in a Medical Conversation
If you already have a low vitamin D result, bring it with the rest of your laboratory reports. Ask whether correction is appropriate for your general health and how the clinician would review ED at the same time. If you have no result, ask whether testing would answer a specific question in your assessment rather than assume that every erection problem reflects a nutrient deficiency.
Our ED treatment page explains medication and other options to discuss. A plan should state which problem each treatment addresses and how you will judge the response.

Comments